/Investor DB

GP Capital

Venture capital

Series A–Series C · 1 people tracked

Find your way into GP Capital

Sign up to see every warm intro you have to GP Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the GP Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit
Stage
Series A–Series C
Tracked investments
1

Team · 1 people

from curated

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Healthtech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Eureka Therapeuticseurekatherapeutics.comin𝕏Jan 2018 · $60M

Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based therapies to treat solid tumors and other cancers.

BiotechHealthtechEmeryville, US

Cheng Liu(Executive Officer, Director)in

BoardSandy Chau(Director)Hsing Kung(Director)Qiushi Fu(Director)Chih-Kai Cheng(Director)inMichael Cannon(Director)

Co-investorsAcorn Pacific VenturesCloudStone CapitalYosemite

Frequently asked questions

What stage does GP Capital invest at?
GP Capital invests at the Series A, Series C stages.
What sectors does GP Capital focus on?
GP Capital focuses on Crypto & Web3.

Similar investors

Featured in lists